Advocates for veterans are championing Assembly Bill 1103, which would fast-track the approval of academic studies on ...

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as ...

Clinical stage biotech Prescient Therapeutics is developing new therapies for cancers of unmet need, including cutaneous ...

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and ...

New open label data in Becker demonstrated sustained disease stabilization up to three years, reinforcing prior clinical findings -- Ongoing pivotal trial and FDA Type C meeting provide ...

The rush job to pass the big beautiful bill has had its intended outcome: not giving the public time to catch on to the ...

Its CEO Bryan Crain wants to one day expand its training mission to fill a jobs gap in the construction industry.